Fundraising FoxSanderling Ventures — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
TheraVidatheravida.comJan 2023
TheraVida is a clinical-stage specialty pharmaceutical company developing combination drug therapies for patients with hyperhidrosis (excessive sweating).
BiotechHealthtechMedical DevicesChapel Hill, US
Benjamin F. McGraw(CEO & Chairman)Rhonda Donahoe(CFO)Assad Kazeminy(VP, Business Development)Mehdi Paborji(Executive Officer, Director)Roger L. Flugel(Executive Officer, Director)Roger S. Flugel(Executive Officer, Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.